Prevalence, Treatment and Antibacterial Resistance of Urinary Tract Infections

Dear Colleagues,

Urinary tract infections (UTIs) are among the most frequently occurring infectious diseases worldwide, affecting individuals of all age groups, genders, and geographical regions. The clinical presentation and effects of UTIs can differ (from mild discomfort to serious complications) but the burden on healthcare systems remains significant. Despite ongoing progress in understanding the pathogenesis of these infections and advances in antimicrobial therapies, our global knowledge about the proliferation and resistance patterns of UTI-causing pathogens remains limited. Additionally, antimicrobial resistance present a growing threat to effective UTI management.

This Special Issue "Prevalence, Treatment and Antibacterial Resistance of Urinary Tract Infections” aims to collate original research articles, reviews, and case studies to deepen our understanding of UTIs.

We invite contributions that focus on topics including, but not limited to, the following:

• UTI prevalence in underrepresented regions or populations, especially where current data are scarce or outdated.
• Patterns of antimicrobial resistance in different clinical settings, including hospitals, long-term care facilities, and community environments.
• Resistance trends in specific pathogens, such as E. coli, Klebsiella spp., or multidrug-resistant organisms.
• The clinical relevance of in vitro resistance findings and their correlation with in vivo treatment outcomes.
• Alternative or non-conventional treatment approaches, including plant-based therapies, phage therapy, or emerging antimicrobial agents.
• Infection management strategies in special populations, such as immunocompromised patients, the elderly, or individuals with recurrent UTIs.

We intend to provide a platform for sharing valuable insights, especially from regions that are currently underrepresented in the literature. Our goal is to contribute to a more complete global picture of UTIs and to support clinicians, microbiologists, and public health professionals in improving prevention and treatment strategies.

We look forward to receiving your contributions and advancing the understanding and management of UTIs around the world.

Dr. Alin Gabriel Mihu
Prof. Dr. Tudor Rares Olariu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• urinary tract infections
• UTI
• antibiotic
• antibacterial
• resistance
• uropathogens
• recurrent UTI
• Enterobacteriaceae
• Escherichia coli